MARK SCHWARTZ: Open Payments
NPI 1659796183 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$49,557 in 66 payments from 3 companies in 2025. Trend: 2023 $244 · 2024 $29,271 · 2025 $49,557
Speaker / faculty: $45,304Travel & lodging: $3,049Food & beverage: $1,204
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $30,270 |
| Lilly USA, LLC | 33 | $19,264 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: Wegovy, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
